Reducing risk from transfusion in patients with sickle cell disease: Indications for transfusion/avoidance of transfusion and alternatives to transfusion

Presented by

Dr. Jacob Pendergrast, MD, FRCPC
Associate Professor, University of Toronto
Medical Director, University Health Network Blood Transfusion Science

Dr. Kevin H.M. Kuo, MD, MSc, FRCPC
Clinician-Investigator and Staff Hematologist Red Blood Cell Disorders Program, Division of Medical Oncology and Hematology, Department of Medicine, University Health Network
Associate Professor Division of Hematology, Department of Medicine, University of Toronto
Associate Professor (status) Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health University of Toronto

Learning objectives

1. To review the physiologic effects of blood transfusion in sickle cell disease
2. To develop an approach to diagnosing delayed hemolytic transfusion reactions
3. To understand current recommendations for the prevention and treatment of hyperhemolysis
4. To describe alternatives to transfusion in treatment of complications from sickle cell disease

Registration

Registration for this event can be completed using this Zoom registration form. 

To receive registration details for all upcoming U of T Transfusion Medicine Rounds directly, join the U of T Transfusion Medicine mailing list via Ontario Regional Blood Coordinating Network (list-manage.com). 

For additional event details about U of T Transfusion Medicine Rounds, refer to the Ontario Regional Blood Coordinating Network (ORBCoN) website: https://transfusionontario.org/en/events/.